The round was co-led by HealthTrend Capital and LFE Capital, with participation from existing investors Base10 Partners and Mairs & Power Venture Capital.

GEM HEALTH removes the frustration of not knowing where to start or the next steps when navigating a new condition. GEM's first product, GEM SLEEP, helps the estimated 30 million people with obstructive sleep apnea find relief. GEM provides a simple guided experience through diagnosis, treatment, and ongoing support, reducing the time to relief from months to weeks. GEM SLEEP treats patients in 50 states and is in-network with 53 million Americans' health plans ensuring broad access to care.